The Third Department of Internal Medicine, Jilin Provincial Tumor Hospital, Changchun, China.
The Second Department of Internal Medicine, Jilin Provincial Tumor Hospital, Changchun, China.
Biomarkers. 2021 Feb;26(1):i-vi. doi: 10.1080/1354750X.2018.1496360. Epub 2020 Sep 1.
We, the Editor and Publisher of Biomarkers, have retracted the following article: Yueming Zhao, Yawen Yang, Jixing Dai, Dejun Xing & Ying Dong (2018) IMPDH2 is highly expressed in breast cancer and predicts unfavourable prognosis, Biomarkers, DOI: 10.1080/1354750X.2018.1496360 The authors have requested retraction of their article after being unable to reach a consensus regarding authorship. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as "Retracted".
我们，《生物标志物》的编辑和出版人，撤回了以下文章：赵月明、杨亚文、代纪兴、邢德文和董莹（2018）IMPdh2 在乳腺癌中高表达，并预测预后不良，生物标志物，DOI：10.1080/1354750X.2018.1496360 作者在无法就作者身份达成一致意见后，要求撤回他们的文章。在我们的决策中，我们遵循了出版道德和诚信政策以及 COPE 关于撤回的指南。被撤回的文章将继续在线以保持学术记录，但每页都会被数字水印标记为“已撤回”。
